23andMe Gets NHGRI Grant | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic testing firm 23andMe said today it has received a $190,000 grant from the National Institutes of Health to validate its platform for pharmacogenomics research.

The Mountain View, Calif.-based company received the funding as part of the American Recovery and Reinvestment Act of 2009 from NIH's National Human Genome Research Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.